TipRanks
California Nanotechnologies Corp (TSE:CNO)
:CNO
Canadian Market
CNO
California Nanotechnologies
RESEARCH TOOLSreports
Want to see TSE:CNO full AI Analyst Report?

California Nanotechnologies (CNO) Ratios

28 Followers

California Nanotechnologies Ratios

TSE:CNO's free cash flow for Q4 2026 was $0.61. For the 2026 fiscal year, TSE:CNO's free cash flow was decreased by $ and operating cash flow was $-0.44. See a summary of the company’s cash flow.
Ratios
TTM
May 26May 25May 24May 22
Liquidity Ratios
Current Ratio
 ― 0.93 0.97 1.94 0.23
Quick Ratio
 ― 0.93 0.97 1.94 0.23
Cash Ratio
 ― 0.23 0.28 0.82 0.03
Solvency Ratio
 ― -0.62 0.13 0.23 0.14
Operating Cash Flow Ratio
 ― -0.42 1.56 0.10 0.02
Short-Term Operating Cash Flow Coverage
 ― -1.19 6.42 0.00 0.04
Net Current Asset Value
$ ―$ -1.04M$ -1.35M$ -219.63K$ -2.06M
Leverage Ratios
Debt-to-Assets Ratio
 ― 0.34 0.30 0.51 1.77
Debt-to-Equity Ratio
 ― 0.66 0.70 8.27 -1.58
Debt-to-Capital Ratio
 ― 0.40 0.41 0.89 2.72
Long-Term Debt-to-Capital Ratio
 ― 0.00 0.00 0.87 0.00
Financial Leverage Ratio
 ― 1.96 2.38 16.15 -0.89
Debt Service Coverage Ratio
 ― -2.92 0.95 7.10 0.21
Interest Coverage Ratio
 ― -15.97 7.21 5.99 2.03
Debt to Market Cap
 ― 0.03 0.02 0.10 0.72
Interest Debt Per Share
 ― 0.03 0.04 0.03 0.07
Net Debt to EBITDA
 ― -0.83 1.39 0.49 6.63
Profitability Margins
Gross Profit Margin
―-21.54%73.77%69.88%37.95%
EBIT Margin
―-71.51%3.25%19.03%15.49%
EBITDA Margin
―-46.43%12.55%22.56%23.23%
Operating Profit Margin
―-71.51%22.20%19.03%11.30%
Pretax Profit Margin
―-66.46%0.17%11.44%17.93%
Net Profit Margin
―-66.60%-2.54%11.44%14.80%
Continuous Operations Profit Margin
―-66.60%-2.54%11.44%14.80%
Net Income Per EBT
―100.22%-1498.94%100.00%82.53%
EBT Per EBIT
―92.93%0.76%60.08%158.71%
Return on Assets (ROA)
―-48.72%-2.88%16.19%16.49%
Return on Equity (ROE)
―-95.49%-6.84%261.47%-14.74%
Return on Capital Employed (ROCE)
―-68.54%38.15%47.76%-14.65%
Return on Invested Capital (ROIC)
―-61.74%-471.35%46.95%38.05%
Return on Tangible Assets
―-48.75%-2.88%16.21%16.56%
Earnings Yield
―-18.56%-0.79%3.77%10.08%
Efficiency Ratios
Receivables Turnover
 ― 4.98 5.05 7.71 3.86
Payables Turnover
 ― 9.37 2.02 3.81 4.45
Inventory Turnover
 ― 0.00 0.00 0.00 1.27M
Fixed Asset Turnover
 ― 0.95 1.72 9.22 1.95
Asset Turnover
 ― 0.73 1.13 1.42 1.11
Working Capital Turnover Ratio
 ― -51.34 13.58 -9.67 -0.72
Cash Conversion Cycle
 ― 34.39 -108.41 -48.51 12.62
Days of Sales Outstanding
 ― 73.35 72.28 47.35 94.61
Days of Inventory Outstanding
 ― 0.00 0.00 0.00 <0.01
Days of Payables Outstanding
 ― 38.96 180.69 95.86 81.99
Operating Cycle
 ― 73.35 72.28 47.35 94.61
Cash Flow Ratios
Operating Cash Flow Per Share
 ― >-0.01 0.07 <0.01 <0.01
Free Cash Flow Per Share
 ― >-0.01 0.02 <0.01 <0.01
CapEx Per Share
 ― <0.01 0.05 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 ― 1.13 0.27 0.86 0.82
Dividend Paid and CapEx Coverage Ratio
 ― -7.60 1.37 7.29 5.68
Capital Expenditure Coverage Ratio
 ― -7.60 1.37 7.29 5.68
Operating Cash Flow Coverage Ratio
 ― -0.30 1.80 0.09 0.03
Operating Cash Flow to Sales Ratio
 ― -0.14 0.47 0.03 0.04
Free Cash Flow Yield
―-4.32%3.96%0.89%2.28%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 ― -5.38 -128.30 26.51 9.92
Price-to-Sales (P/S) Ratio
 ― 3.59 3.23 3.03 1.47
Price-to-Book (P/B) Ratio
 ― 5.15 8.69 69.32 -1.46
Price-to-Free Cash Flow (P/FCF) Ratio
 ― -23.14 25.26 112.45 43.96
Price-to-Operating Cash Flow Ratio
 ― -26.19 6.89 97.03 36.22
Price-to-Earnings Growth (PEG) Ratio
 ― >-0.01 0.95 0.13 -0.04
Price-to-Fair Value
 ― 5.15 8.69 69.32 -1.46
Enterprise Value Multiple
 ― -8.56 27.18 13.92 12.95
Enterprise Value
 ― 11.27M 21.22M 10.48M 4.08M
EV to EBITDA
 ― -8.56 27.18 13.92 12.95
EV to Sales
 ― 3.98 3.41 3.14 3.01
EV to Free Cash Flow
 ― -25.64 26.63 116.51 90.03
EV to Operating Cash Flow
 ― -29.02 7.26 100.53 74.18
Tangible Book Value Per Share
 ― 0.04 0.05 <0.01 -0.04
Shareholders’ Equity Per Share
 ― 0.04 0.05 <0.01 -0.04
Tax and Other Ratios
Effective Tax Rate
 ― >-0.01 15.99 0.00 -0.03
Revenue Per Share
 ― 0.06 0.14 0.09 0.04
Net Income Per Share
 ― -0.04 >-0.01 0.01 <0.01
Tax Burden
 ― 1.00 -14.99 1.00 0.83
Interest Burden
 ― 0.93 0.05 0.60 1.16
Research & Development to Revenue
 ― 0.00 <0.01 0.00 0.00
SG&A to Revenue
 ― 0.50 0.32 0.35 0.21
Stock-Based Compensation to Revenue
 ― 0.00 0.08 0.11 <0.01
Income Quality
 ― 0.21 -18.47 0.27 0.22
Currency in USD